Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

COVID-19 GPH|Home|PHGKB Last data update: May 18, 2022 . (Total: 35574 Documents since 2020)

Last Posted: May-18-2022 16:44:24
spot light Spotlight

Routine Surveillance and Vaccination on a University Campus During the Spread of the SARS-CoV-2 Omicron Variant
GR Meredith e al, JAMA Network Open, May 18, 2022

The Omicron variant is highly transmissible, particularly in high-density social settings.5,6 Based on analysis of routinely collected population surveillance data, Cornell’s experience shows that traditional public health interventions were not a match for Omicron. While vaccination protected against severe illness, it was not sufficient to prevent rapid spread, even when combined with other public health measures including widespread surveillance testing.

Priority COVID-19 Public Health Science Questions
CDC, May 17, 2022

It remains important to collect data-driven information on key priority areas that can help CDC and public health partners continue to fill critical scientific gaps, build on knowledge gained and advances made, and inform evidence-based decision-making for continued intervention through public health surveillance and epidemiologic research. CDC has developed priority questions around 8 thematic topic areas for The CDC Public Health Science Agenda for COVID-19: health equity, vaccines, variants, prevention, testing, treatment, natural history and post-COVID conditions.

Genomic outbreak surveillance in resource-poor settings
L Musila, Nat Rev Genetics, May 16m 2022

The SARS-CoV-2 pandemic fueled massive growth in sequencing capability, with more countries beginning to conduct routine genomic epidemiological surveillance, mainly because of the accessibility and ease of use of portable nanopore sequencers. But we should not wait for the next pandemic to achieve full genomic equity, enabled by the end-to-end capability to sequence and analyze genomic data for public health in under-resourced settings!

Limited cross-variant immunity from SARS-CoV-2 Omicron without vaccination
RK Suryawanshi et al, Nature, May 18, 2022

SARS-CoV-2 Delta and Omicron are globally relevant variants of concern (VOCs). While individuals infected with Delta are at risk to develop severe lung disease, infection with Omicron often causes milder symptoms, especially in vaccinated individuals1,2. The question arises whether widespread Omicron infections could lead to future cross-variant protection, accelerating the end of the pandemic. Here we show that without vaccination, infection with Omicron induces a limited humoral immune response in mice and humans.

news Latest News and Publications
Human-to-dog transmission of SARS-CoV-2, Colombia.
Rivero Ricardo et al. Scientific reports 2022 5 (1) 7880

New Added Today

Super Dominant Pathobiontic Bacteria in the Nasopharyngeal Microbiota Cause Secondary Bacterial Infection in COVID-19 Patients.
Qin Tian et al. Microbiology spectrum 2022 5 e0195621

New Added Today

Applications of Robotic Process Automation in Smart Governance to Empower COVID-19 Prevention.
Wang Shiguo, et al. Procedia computer science 2022 0 0. 320-323

New Added Today

Advancement of deep learning in pneumonia/Covid-19 classification and localization: A systematic review with qualitative and quantitative analysis.
Shah Aakash, et al. Chronic diseases and translational medicine 2022 0 0.

New Added Today

Combining the advantages of AlexNet convolutional deep neural network optimized with anopheles search algorithm based feature extraction and random forest classifier for COVID-19 classification.
Akbar Sumaiya Begum, et al. Concurrency and computation : practice & experience 2022 0 0. e6958

New Added Today

Predicting the Mass Adoption of eDoctor Apps During COVID-19 in China Using Hybrid SEM-Neural Network Analysis.
Yang Qing, et al. Frontiers in public health 2022 0 0. 889410

New Added Today

When Patients Recover From COVID-19: Data-Driven Insights From Wearable Technologies.
Guo Muzhe, et al. Frontiers in big data 2022 0 0. 801998

New Added Today

Development of Keyword Trend Prediction Models for Obesity Before and After the COVID-19 Pandemic Using RNN and LSTM: Analyzing the News Big Data of South Korea.
Eom Gayeong, et al. Frontiers in public health 2022 0 0. 894266

New Added Today

Machine Learning-Based Prediction Models for Depression Symptoms Among Chinese Healthcare Workers During the Early COVID-19 Outbreak in 2020: A Cross-Sectional Study.
Zhou Zhaohe, et al. Frontiers in psychiatry 2022 0 0. 876995

New Added Today

A chronological and geographical analysis of personal reports of COVID-19 on Twitter from the UK.
Golder Su, et al. Digital health 2022 0 0. 20552076221097508

New Added Today

All Latest

About COVID-19 GPH

COVID-19 GPH is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other materials that capture emerging discoveries and applications of genomics, molecular and other precision medicine and precision public health tools in the investigation and control of COVID-19. Contents include PubMed records via an automated pubmed search algorithm, preprint records from NIH iCite, the relevant information from many media sources picked by experts, and linkages to contents from our curated PHGKB databases.
update trend

Sign up Email Alert


All Records35574
Genomics Precision Health25689
Non-Genomics Precision Health9885

Publication Categories Brand

Variants 8622
Vaccines 7874
Mechanism 7609
Treatment 7225
Diagnosis 5207
Prevention 4200
Surveillance 3013
Forecasting 2772
Transmission 1607
Health Equity 912

Publication Types

PubMed Records26091
Online News/Reports/Publications431

Genomics Precision Health (GPH): The use of pathogen and human genomics and advanced molecular detection methods in discovery, clinical and public health investigations and response to COVID-19.
Non Genomics Precision Health (non-GPH): The use of big data, data science, digital health, machine learning and predictive analytic methods (not involving genomics) in discovery, clinical and public health investigations and response to COVID-19

Following categories are annotated by LitCovid from NCBI NIH.
MechanismUnderlying cause(s) of covid-19 infections and transmission & possible drug mechanism of action
Transmission Characteristics and modes of covid-19 transmissions, such as human-to-human
DiagnosisDisease assessment through symptoms, test results, and radiological features
PreventionPrevention, control, response and management strategies
Case ReportDescriptions of specific patient cases
ForecastingModelling and estimating the trend of covid-19 spread

Following categories are annotated by the text mining tool from CDC PHGKB
Health EquityRelevant to health equity. Search terms are derived from a list provided by the Association for Territorial Health Officials which include terms such as diversity, health disparities, and others.
VaccineRelevant to vaccine development, evaluation, implementation and impact. For additional information on vaccines and COVID-19. Check out general CDC Information pages
VariantRelevant to SARS-CoV-2 variants and their impact on public health. For additional information on variants COVID-19. Check out CDC New Variants of the Virus that Causes COVID-19 page
SurveillanceRelevant to SARS-CoV-2 public health surveillance and tracking. For additional information on COVID-19 surveillance, check out CDC COVID-19 Data Tracker

Disclaimer: Articles listed in the Public Health Genomics and Precision Health Knowledge Base are selected by the CDC Office of Public Health Genomics to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.